About this trial
This study is to build a cohort of sudden sensorineural hearing loss (SSNHL) patients. When the patient visited the Department of otolaryngology clinic for hearing loss, we can diagnose the SSNHL following the result of pure tone audiometry and the history of the patient. The cohort is a system that tracks the hearing recovery status, timing, and degree of recovery of patients who received cocktail therapy with or without high-dose steroids, vasodilators, antiviral agents, and intratympanic steroid injections, satellite ganglion block, and hyperbaric oxygen therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients over 20 years of age
A patient who visited Wonju Severance Christian Hospital, Department of Otolaryngology and was diagnosed with sudden hearing loss as it was confirmed that hearing loss of 30dBHL or more occurred within 3 days at three consecutive frequencies in a pure tone audiometry test.
Those who have fully explained the purpose and content of the study and voluntarily agreed to the written consent
Disqualifiers
If the patients do not want to or do not fill out the consent form
If treatment is started for sudden hearing loss, but the possibility of other inner ear diseases including Meniere's disease is suspected due to repeated hearing loss, repeated recovery, dizziness, tinnitus, etc.
Other cases where it is judged difficult to carry out the clinical trial due to the judgment of the person in charge of the above clinical trial
Trial population
Among the adults over 20yrs of age, diagnosed sudden sensorineural hearing loss at Wonju Severance Christian Hospital, Department of otolaryngology.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Hearing outcome 1 week - PTA
Hearing change status near 1 weak after treatment start measured by pure tone audiometry1
Hearing outcome 3 weeks - PTA
Hearing change status near 3 weaks after treatment start measured by pure tone audiometry
Hearing outcome 2 months - PTA
Hearing change status near 3 weaks after treatment start measured by pure tone audiometry
Hearing outcome 3 months - PTA
Hearing change status near 3 months after treatment start measured by pure tone audiometry
Secondary outcomes
Electrolytes and chemistries after high dose steroid therapy
The results of blood tests of electrolytes and chemistries at 5 days after treatment start. (Na, K, Cl, CO2, BUN, Cr, Glucose, Amylase, Total protein, Albumin, AST, ALT, ALP, r-GT, Total Bilirubin)
Other outcomes
Internal Acoustic canal MRI
The baseline studies of internal acoustic canal MRI results of SSNHL patients.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.